Uncontrolled Gout Treatment Study

Uncontrolled Gout Treatment Study
Gout is the most common form of inflammatory arthritis in men and is associated with a decrease in quality of life. The frequency of gout is increasing and is characterized by ongoing symptoms of active disease and a failure to maintain/control serum uric acid (sUA) below 6mg/dL. These patients often have significant, disabling urate deposits in soft tissues and bone known as tophi. Napa Research has a clinical research study aimed at reducing the recurrence of the symptoms of gout by means of different combination treatment groups.
Mode of administration:
IV and orally
The study duration: 24 Weeks
Participants will attend approximately 14 study site visits and receive 2 follow-up checks following the completion of the study.
Compensation package includes:
$25 Pre-screening
$130 for screening
$130 for each visit to study site
All study medication, assessments and examinations are free to the participants.
Inclusion Questions:
Has the patient been diagnosed with Gout? (YES/ NO)
Does the patient have 1 or more rounded lumps of nodules (tophus)?
Has there been any recurrent flares (2 or more) in the past 12 months?
Patient’s other medical conditions: